Illumina Inc Completes Acquisition Of Verinata Health Inc

Illumina Inc announced it has completed its previously announced acquisition of Verinata Health, Inc., a provider of non-invasive tests for the early identification of fetal chromosomal abnormalities. As of the close, Verinata Health became a wholly owned subsidiary of Illumina. With completion of the acquisition, Illumina now has access to Verinata`s verifi prenatal test and to the most comprehensive intellectual property portfolio in the NIPT industry. As previously announced, the verifi test will continue to be offered through Verinata`s CLIA- and CAP-accredited laboratory, and the company will continue to generate the clinical data necessary for future regulatory submissions. Terms of the transaction were not disclosed.